Uncategorized Archives - Page 50 of 65

The Authors’ Own Words: Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

Dec 12, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

Sara A. Lorkiewicz, MS; Alicia S. Ventura, MPH; Timothy C. Heeren, PhD; Michael R. Winter, MPH; Alexander Y. Walley, MD, MSc; Meg Sullivan, MD; Jeffrey H. Samet, MD, MA, MPH; & Richard Saitz, MD, MPH

Substance Abuse Vol. 39, Iss. 1, 2018

“Alcohol and other drug use are common among people with HIV infection. HIV can be neurotoxic, alcohol is a known neurotoxin and marijuana can alter brain metabolism and affect neuronal networks. In this study, although effects of alcohol use were not detected, current marijuana use was associated with cognitive dysfunction. The association is particularly important because people with HIV infection may already be susceptible to cognitive dysfunction, and such dysfunction could interfere with their self-care and quality of life.”

The Authors’ Own Words: A Clinical Instrument to Guide Brief Interventions for Adolescents with Substance Use Concerns

Dec 11, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

A Clinical Instrument to Guide Brief Interventions for Adolescents with Substance Use Concerns

Mary M. Ramos, MD, MPH; Teddy Warner, PhD; Daisy V. Rosero; & Timothy P. Condon, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“The paper by Ramos, et al, introduces the CHISPA, a brief clinical guidance tool for adolescent substance use that was designed in conjunction with AAP guidelines for Adolescent SBIRT. To our knowledge, the CHISPA is the first tool that was specifically designed to assist clinicians in gathering information and identifying problems to aid in brief intervention. This appears to be an important innovation in screening and brief intervention tools. Although originally developed to be used in conjunction with positive CRAFFT screens, using the CHISPA in combination with one of the newer and more efficient screens, the S2BI or BSTAD, may be another potential approach. As well, the CHISPA may prove useful in supporting brief interventions as youth are followed over time.”

The Authors’ Own Words: Country-wide distance training for delivery of screening and brief intervention for problematic substance use: A pilot evaluation of participant experiences and patient outcomes

Dec 11, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Country-wide distance training for delivery of screening and brief intervention for problematic substance use: A pilot evaluation of participant experiences and patient outcomes

Ana Paula Leal Carneiro, PhD & Maria Lucia Oliveira Souza-Formigoni, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“Although Screening and Brief Interventions directed to substance users (SBI) have shown satisfactory results when applied by health professionals trained face-to-face, there are few data on its effectiveness when applied by professionals trained through Distance Learning (DL) courses. In this manuscript we showed that health professionals or social workers evaluated some years after having completed the Distance Learning (DL) course SUPERA had incorporated SBI in their work setting and were feeling very motivated to do it. Patients who had received SBI applied by those professionals showed a significant reduction in alcohol, tobacco and cocaine/crack related problems (reduction in WHO-ASSIST scores) three months after the intervention, indicating the effectiveness of the SBI applied. Providing an effective DL training on SBI techniques can have a significant impact on reducing substance use related problems, mainly in continental countries where the cost of massive face-to-face training is very high.”

The Authors’ Own Words: The willingness of people who inject drugs in Boston to use a supervised injection facility

Dec 10, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The willingness of people who inject drugs in Boston to use a supervised injection facility

Casey León, MPH; Lena Cardoso, BA; Sarah Mackin, MPH; Barry Bock, RN; & Jessie M. Gaeta, MD

Substance Abuse Vol. 39, Iss. 1, 2018

“This manuscript identifies characteristics associated with willingness to use supervised injection facilities by self-report of people who use injection drugs. The results of this study suggest that a supervised injection facility (SIF) in an urban area in the United States would be well accepted by people who inject drugs, as the overwhelming majority of study participants reported willingness to use such a facility. People at high risk for overdose and people who contribute to the public burden of injection drug use were significantly more likely to be willing to use a SIF – suggesting that the ideal target population for supervised injection would be those most willing to use a SIF. The information can directly influence the policy, advocacy, and implementation of a SIF in the United States.”

The Authors’ Own Words: Interprofessional Prescription Opioid Abuse Communication among Prescribers and Pharmacists: A Qualitative Analysis

Dec 10, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Interprofessional Prescription Opioid Abuse Communication among Prescribers and Pharmacists: A Qualitative Analysis

Nicholas E. Hagemeier, PharmD, PhD; Fred Tudiver, MD; Scott Brewster, PharmD; Elizabeth J. Hagy, PharmD; Brittany Ratliff, Angela Hagaman, MA; & Robert P. Pack, MPH, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“Prescription opioid-related default communication behaviors among and between prescribers and community pharmacists were routinely not patient-centered in our study. Hopefully, this qualitative study will inform future work and lead to increased emphasis on communication skill building among prescribers and pharmacists. The extent to which the prescription monitoring program has replaced verbal interprofessional communication was noteworthy, as was the extent to which indirect interprofessional communication occurs via patients. In my opinion, top-notch communication skills are often assumed to be factory installed in health providers. This study indicates we have some work to do.”